Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Avalo Therapeutics, Inc./ 10-K

Annual Report · 10-K

Avalo Therapeutics, Inc.

AVTXNASDAQEQUITYCurrent

Annual Report

Filed Mar 23, 2026Accepted Mar 23, 2026, 7:02 AM EDTCIK 1534120Accession 0001534120-26-000011
View company →Permanent SEC source ↗
Share

Company context

Current securities

AVTXNASDAQ · EQUITY · Current
Historical securities (2)
CERCWNASDAQ · WARRANT · Historical · closed Oct 18, 2018CERCZNASDAQ · WARRANT · Historical · closed Apr 18, 2017

Recent company filings

  1. 144 filingAug 17, 2026
  2. SCHEDULE 13G/A filingAug 14, 2026
  3. SCHEDULE 13G/A filingAug 14, 2026
  4. SCHEDULE 13G/A filingAug 14, 2026
  5. SCHEDULE 13G/A filingAug 14, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗